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Consumer Attention to an Over-the-counter Warning in Four
Different Styles of Design
By Abhishek Gawasane, Laura Bix,* Javier de la Fuente, Raghav Prashant Sundar and
Timothy J. Smith
School of Packaging, Michigan State University, East Lansing, MI 48824, USA

The study consisted of three objectives: (a) to test the relative prominence and conspicuousness of a warning
required by US law to be conspicuous; (b) to explore whether or not the conspicuousness of the said warn
ing can be enhanced graphically; and (c) to develop preliminary data for power analysis that would guide
decisions related to sample size in future studies.
Seventeen subjects viewed four over-the-counter drug packages (each with a different style of warning)
along with ﬁve other products while wearing an eye tracking device. Four styles of warning were used on
the over-the-counter drug packages: no outline and no ﬁll, outline and no ﬁll, no outline and ﬁll, and outline
and ﬁll. The surface area and the placement of the warnings were held constant across all four designs and
were consistent with those on commercially available products. Collected data were broken into ﬁve zones:
warning, brand name, strength, product beneﬁt and net weight.
Despite the fact that US law requires it to be conspicuous, the tested warning was signiﬁcantly less no
ticeable than the brand name (objective one) for all dependent variables analyzed (a = 0.05). No signiﬁcant
difference was indicated for the varied warning designs (objective two). This could be because not much
can be done to enhance prominence when constrained to the limited space that is typically used for
such warnings or because of the limited sample size. Power calculations suggest that a sample size of nearly
200 subjects would be required to detect a 2.5 s mean difference at 80% conﬁdence (objective three).
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INTRODUCTION
Risk is pervasive. Whether we are at home, at work or travelling from one place to another, risks are
involved. Warnings are intended to help reduce or eliminate risks. However, for a warning to be effec
tive, there must be exposure to the warning, attention to the warning, active processing of the warning,
comprehension and agreement with the warning, storage in memory (as well as search and retrieval),
response selection and response performance. Failures at any of these stages have the potential to reduce
a warning’s effectiveness.1–4
Recent years have seen an increase in warning-related research. Researchers attribute this to varied
reasons; the three main reasons are as follows:5
• Increasing healthcare costs (in the USA and around the world).
• Increasing importance of warnings in litigation and court cases.
• Increasing emphasis on warnings by organizations such as the US Environmental Protection
Agency) and the US Occupational Safety and Health Administration.
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Warnings are frequently classiﬁed into three large spheres. Those that
• Prevent dangerous practices, such as smoking in gas stations or being exposed to sunlight while
taking certain drugs.
• Catalyse behavioural change; a warning suggesting protective gear is one such example.
• Enable informed decisions. For example, a warning that indicates the risks associated with alcohol
consumption during pregnancy or statutory cigarette warnings.6
The model. We frame our study within the context of an information processing model. Information
processing models focus on the stages that warnings pass through while being transmitted from the
environment to the user. Such models take into account multiple facets that have the potential to
inﬂuence the success or failure of the message.6 Information processing theories often mention that
the information passes through stages in serial fashion and that failure at any stage will lead to failure
of subsequent steps.
A commonly used theory of information processing indicates that the following four steps must be
completed for the warning to be effective.2–4,7,6
1. The information must be noticed.
2. It must be encoded into memory. For this to happen, the message must be gathered through
perceptual systems and converted from an external representation into an internal one.
3. The encoded message must then be comprehended.
4. It must, ﬁnally, move the reader to the appropriate action.
Because of the sequential and serialized nature implicit in information processing, many pieces of leg
islation and regulation mandate that certain informational items appear ‘conspicuously’ or ‘prominently’
on package labels (see Table 1). Without sufﬁcient prominence, an item is not noticeable, precluding the
ability of the consumer to proceed with further processing. Although a limited number of ofﬁcial docu
ments do prescriptively address things like minimum type size and make vague statements like ‘sufﬁcient
contrast’, the deﬁnitions of ‘prominence’ and ‘conspicuousness’ are vague throughout the mandates.
For this study, we investigated the relative prominence of the warning, ‘This package for households
without young children’ (stage one of the information processing model). The Poison Prevention
Packaging Act of 1970, 15 U.S.C. pages 1471–1476, requires child resistant closures on most hazardous
household substances; this includes drugs as deﬁned in Section 201 of the Federal Food, Drug and
Cosmetic Act, 21 U.S.C. page 321.8 One size of over-the-counter (OTC) product may be exempted
from the requirement for a child resistant feature, provided it is ‘conspicuously labelled’ with
the aforementioned warning. Yet previous research suggests that across several OTC products
containing acetaminophen, this warning was consistent in both
• Its design (most were present in the lower left hand corner of the package and of consistent size).
• Its inability to garner attention as measured by eye tracking.9
This led us to wonder ‘if constrained by available space on the principal display panel (PDP), is
there a way that warnings could be graphically enhanced to garner attention?’ In other words, if man
ufacturers are limited to a small space in the lower left hand corner of these packages, is there anything
that be carried out to make the warning more noticeable? Holding the warning placement to the lower
left hand corner of the PDP and limiting the allowable surface area to a 43 mm x by 4 mm rectangular
space (172 mm2), an area and placement based on the commercial products we used for previous
study,9 we investigated the effects of two design elements, outline and ﬁll, on the noticeability of
the warning as measured by eye tracking.
This is in accordance with the ‘theory of pre-attentive processing’, described by Wogalter et al.
as follows:
‘Pre-attentive processing’ suggests that information (e.g. a warning), if designed properly with re
spect to the background, can ‘pop out’ and attract attention without conscious control on the part
of the individual. For example, if an individual is shown a random conﬁguration of 100 equal size
dots, a single red dot embedded in 99 blue dots will ‘leap off the page’ and be detected prior to any
conscious, attentive processing on the part of the individual.10

Table 1. US documents that mandate and deﬁne prominence and conspicuousness.
Document

Area

21 CFR Section 207.35(b)(3)

Prescription
drugs

21 CFR Section 201.15 (a)(1–6)

Drugs

Medical Device User Fee and
Modernization Act (MDUFMA)
of 2002 (Public Law 107-250) –
Amends Section 502 of the Federal
Food Drug and Cosmetic Act
Guidance for Industry and FDA
staff: compliance with Section 301
of the MDUFMA of 2002, as
amended – Prominent and
Conspicuous Mark of Manufacturers
on Single-Use Devices.
27 CFR Chapter 8 Subchapter II
Section 215b

Device

Device

Alcoholic
beverages

27 CFR Section 16.22

Alcoholic
beverages

40 CFR Section 156.10

Pesticides

Description
Requests the presence of an NDC on all drug labels
and other drug labelling including the label of any
prescription drug container furnished to a consumer.
If the NDC is shown on a label, it shall appear
‘prominently’ in limited locations.
General labelling provisions – Reasons for failure
with regard to prominence and conspicuousness.
Failure to appear. Failure to present in enough
places. Failure to extend over the available area.
Insufﬁciency of space for prominent placement
(for varied reasons, including devoting greater
conspicuousness to other label elements). Size or
style of type, insufﬁcient contrast, obscuring
designs, crowding.
Requires a device or attachment to the device to
bear prominently and conspicuously the name of the
manufacturer, a generally recognized abbreviation of
such name or a unique and generally recognized
symbol identifying the manufacturer.
Prominent and conspicuous is deﬁned in a guidance
compendium to MDUFMA as ‘A manner of marking
a device, as required by section 502(u) of the Act, such
that the manufacturer’s mark is apparent to the user
under ordinary conditions of use.’
Surgeon General’s required warning ‘GOVERNMENT
WARNING: (1) According to the Surgeon General,
women should not drink alcoholic beverages during
pregnancy because of the risk of birth defects (2)
consumption of alcoholic beverages impairs your
ability to drive a car or operate machinery, and may
cause health problems’ is required to be ‘conspicuous
and prominently’ placed on the container in
‘contrasting background’
Required warning shall be stated on brand label or
separate front label, back or side panel. Separate from
other information. Readily legible under ordinary use
conditions. Statement beyond ‘GOVERNMENT
WARNING’ may not appear in bold. Remaining text
shall not be compressed in such a manner that the
warning is not readily legible. Containers of 8 ﬂ oz or
less = text not less than 1 mm. 8 ﬂ oz–3 l = not smaller
than 2 mm. Greater than 3 l = not smaller than 3 mm.
All words, statements, graphic representations, designs
or other information required on the labelling by the
Act or the regulations in this part must be clearly
legible to a person with normal vision and must be
placed with such conspicuousness (as compared with
other words, statements, designs or graphic matter on
the labelling) and expressed in such terms as to render
it likely to be read and understood by the ordinary
individual under customary conditions of purchase and
use. Six points or larger type. Clear and contrasting
background. Not obscured or crowded.

CFR, Code of Federal Regulations; NDC, National Drug Code Number; FDA, Food and Drug Administration.

OBJECTIVES
1. To investigate the conspicuousness of the warning (stage 1 of the information processing model)
relative to other label elements, speciﬁcally the brand name, strength, net contents and product
beneﬁt.
2. To explore how varying graphic elements (an outline and background ﬁll) impact its noticeability
when the placement and surface area of the warning are held constant.
3. To develop preliminary data for power analysis that would guide decisions related to sample size
in future studies.
MATERIALS AND METHODS
Test participants. Useable data were collected from 17 participants from a population that consisted
primarily of students between the ages 18 and 25 years following procedures approved under IRB
06–054. Participants were at least 18 years or older and were not legally blind. Upon arrival, partici
pants were assigned a ‘participant number’ and were characterized by gender and visual acuity.
Visual acuity test. Each participant’s visual acuity was tested and recorded using a near point visual
acuity card manufactured by Dow Corning Ophthalmic. The subjects were asked to hold the card
approximately 16 in. from their eyes and were asked to read the lowest line possible. This line corre
sponded with the subject’s near point visual acuity (e.g. 20/20 and 20/30).
Instrument – Applied Science Laboratories eye tracker. An Applied Science Laboratories 501
head mounted bright pupil system (Boston, MA, USA) was used to record participant’s eye move
ments. Once the eye tracking equipment was comfortably placed on the head, the calibration sequence
began. For calibration and testing, subjects were seated at a special table ﬁxtured with a glass pane and
a chin rest. This set-up allowed subjects to examine packages at a consistent and ﬁxed distance from
their eyes. The calibration sequence employed a ﬂoating technique that consisted of nine dots distrib
uted equally across the pane of glass. By ﬁxing the distance and limiting subject movement, the set-up
minimized parallax error, enhancing accuracy of the tracking of the gaze trail on the package surface.
Following calibration, participants were instructed that they were being asked to examine a series of
items that appeared on a shopping list that they had been given (see Table 2). They were asked to re
view packages as they would in the store when making a purchase decision for their household (sum
mary of the experimental design shown in Figure 1). They were told that they could view any side
of the package that they wished but were instructed to press packages against the glass pane (the cali
brated plane) as they did.
Following this instruction, nine packages were handed to the subject for viewing in an order that
was counterbalanced across subjects. Participants viewed each of the nine packages for a time period
of 10 s before being handed the next product. Ten seconds was chosen as a conservative estimate
because sources indicate that consumers generally take 5–7 s examining packages while shopping.11

Table 2. The nine packages used for the experiment.
Package

Number
Brand
1
2
3
4
5
6
7
8
9

Vanish
Tyvedron
Nature Valley
Tyvedron
Grand River Falls
Tyvedro
Elsa’s Story
Tyvedron
PG Tips

Warning characteristics

Product

Size

Toilet bowl cleaner
Pain reliever
Almond granola bars
Pain reliever
Tomato basil crackers
Pain reliever
Black pepper crackers
Pain reliever
Tea bags

1.7 oz
24 gel caps
7.4 oz
24 gel caps
1.75 oz
24 gel caps
5.29 oz
24 gel caps
4.4 oz

Text colour

Background

Outline

N/A
White
N/A
White
N/A
Dark blue
N/A
Dark blue
N/A

N/A
Dark blue
N/A
Dark blue
N/A
White
N/A
White
N/A

N/A
No
N/A
White
N/A
No
N/A
Dark blue
N/A

Figure 1. Experimental design.
This is also consistent with the studies performed by Krugman et al. where subjects were eye tracked
while viewing tobacco advertisements. The time spent by the average reader ranged between 3.2 and
14.7 s when they viewed the advertisements without any time restrictions.12
Stimulus material. As mentioned, the size, placement and content of the warning on the PDPs were
held constant (see Figure 2); the warning design was not. The warning text was comprised of eightpoint Swiss 911 Ucm BT font in navy blue (Pantone Matching System 184–1). Warnings were created
to test for an effect of two design elements, outline and ﬁll, on the ability to garner subject attention.
Two levels of each of the elements were crossed such that four designs were tested (See Figure 2 and
3):
•
•
•
•

Warning
Warning
Warning
Warning

1 (no outline and no ﬁll).
2 (outline and no ﬁll).
3 (no outline and ﬁll).
4 (outline and ﬁll).

Statistical analysis. Eye tracking data were collected in the form of video ﬁles and analyzed using
Gaze TrackerW (purchased through Applied Science Laboratories, Boston, MA) eye tracking
analysis software. All dependent variables tested were ﬁrst examined for an effect of run order;
no effect of order was suggested at αa = 0.05 for all variables. During the analysis phase of the
experiment, ﬁve zones (see Figure 4) were created on all four stimulus packages (see Figure 2).

Figure 2. Principal display panels of the four Tyvedron packages used as stimulus.
The ﬁve zones were brand name, warning (four levels), net content, strength and product beneﬁt
(i.e. nondrowsy). Brand name, net content, strength and product beneﬁt were identical on all four
packages of Tyvedron used in the study. Only the warning zone was changed (see Figures 2
and 3). Three dependent variables were used in the analyses:
1. Time spent in zone (a variable response).
2. Probability of a zone being hit ﬁrst (zone hit ﬁrst; yes/no; a binary response).
3. The number of visual hits to a zone (a discrete response variable).
Statistical analysis was then carried out using SAS version 9.2 (SAS Institute Inc., Cary, NC,
USA).13 Zone, package, gender and their interactions were included in the model as ﬁxed independent
variables, and subject was considered a random factor in the analysis of variance. Time in zone, prob
ability of a zone being hit ﬁrst and visual ‘hits’ to a zone were considered response variables. Normal
ity and equality of variances assumptions were checked visually using normal plots and side-by-side
box plots. Because of right skewness, both time and hits had to be transformed (log-transformed for
time and square root for hits). Least square mean estimates and 95% conﬁdence intervals were carried
out for the sake of post-hoc comparisons.

RESULTS AND DISCUSSION
Dependent variable – total time spent in a zone
When time was the dependent variable, zone (p < 0.0001), zone x gender (p = 0.0527) and package x
gender (p = 0.0300) were found to be signiﬁcant (a = 0.05). Consistent with previous work,9 brand
name garnered signiﬁcantly more attention than any other aspect of the label when time in zone was

Figure 3. Design of warnings (dimensions are in millimetre; those marked with an asterisk correspond
to the centre of the outline).

Figure 4. Zones of test stimulus.

the dependent variable of interest (see Figure 5). The zone warning received signiﬁcantly less attention
than all other zones tested except for strength, only garnering an estimated 0.03 s per viewing.
The analysis of variance also indicated a marginal effect of the interaction term zone by gender
on time per zone (p = 0.0527). To further explore this effect, pairwise comparisons were made
using least square mean differences. When all ﬁve zones were examined for gender effects, only
zone 1, warning, was suggested to be signiﬁcant (p = 0.0344). Male subjects spent more time
(0.08 s) on the warning zone when compared with their female (0.01 s) counterparts. This contra
dicts prior research speciﬁcally designed to research the effect of gender on the noticeability of
warning labels. The reviewed literature suggests female subjects have a greater tendency to look
at warnings than male counterparts.14–16

Figure 5. Estimate of time spent in a zone.
Total time in zone 1 – warning. To speciﬁcally explore how varying the graphic and textual elements
(an outline and background ﬁll) impacted the time spent on the warning label when its placement and
surface area were held constant, we conducted a second analysis that just looked at the time spent on
zone 1 (the warnings) (see Table 3) in the form of a 2 x 2 factorial that considered ﬁll and outline each
at two levels as well as the interaction term. Because of the failure of the data to meet model assump
tions, data were log-transformed for the statistical analysis. This analysis did not provide evidence of
an effect of warning design on the time spent in the warning zone (p > 0.05).

Table 3. Time spent on Zone 1 – warning (averaged across all the subjects).
Warning

Treatment

Total time spent (seconds)

Warning 1 (no outline, no ﬁll)

4.0

Warning 2 (outline, no ﬁll)

3.9

Warning 3 (no outline, ﬁll)

6.3

Warning 4 (outline, ﬁll)

6.7

Probability of a zone being hit ﬁrst
We also analyzed the ability of each zone to draw the eye, i.e. the probability of a zone being hit ﬁrst
(see Table 4). Statistical analysis indicated that the probability of being visually ‘hit ﬁrst’ was signiﬁ
cantly affected by the zone (p < 0.0001); i.e. some zones were more likely to be hit ﬁrst than others. No
other factors provided evidence of a signiﬁcant difference (a = 0.05). Post-hoc pairwise comparisons
suggest that brand name (zone 2) had a signiﬁcantly higher probability of being hit ﬁrst (52%) than
any other zone (a = 0.05) (see Figure 6).

Table 4. Frequency table: number of ﬁrst hits in a given zone by package.

Zone

Package with
warning 1
(no outline, no ﬁll)

Package with
warning 2
(outline, no ﬁll)

Package with
warning 3
(no outline, ﬁll)

Package with
warning 4
(outline, ﬁll)

0
12
1
3
1

1
10
2
2
1

2
4
3
3
5

2
8
1
4
2

Warning (Zone 1)
Brand name (Zone 2)
Strength (Zone 3)
Product beneﬁt (Zone 4)
Net content (Zone 5)

Please note that eye tracking data were not available for one subject viewing the package with warning 2.

Figure 6. Probability of a zone to be hit ﬁrst.
Visual hits in a zone
Further analysis examined data for an effect on the number of visual hits garnered. As before, the fac
tors for consideration were subject, zone, package and gender, as well as all interactions. Only subject
was considered a random effect. Zone had a signiﬁcant effect on the number of hits (p < 0.0001), and
the interaction term package x gender was also indicated to be signiﬁcant (p = 0.0043). Post-hoc, least
square mean comparisons suggested that the brand name (zone 2) received a statistically signiﬁcant
greater amount of attention when the number of hits to the zone was the dependent variable (See

Figure 7. Estimate of number of hits in a zone.
Table 5. Frequency table: number of hits and average number of hits on Zone 1 – warning
(across all subjects).
Treatment
Warning
Warning
Warning
Warning

1 (no outline, no ﬁll)
2 (outline, no ﬁll)
3 (no outline, ﬁll)
4 (outline, ﬁll)

Total number of hits by Warning
type (for all subjects)

Average number of
hits per subject

23
21
23
29

1.35
1.31
1.35
1.71

Figure 7). Strength and product beneﬁt were preferentially attended as compared with warnings and
net contents at a = 0.05.
Number of hits with respect to the treatments in zone 1 – warning. Data were also analyzed to
explore objective 2, whether or not graphic elements could be manipulated to create a warning that
garnered more attention, despite being constrained by placement and area. Preliminary analysis of zone
1 data indicated that when the dependent variable was the probability of ﬁrst hit, only ﬁve subjects
(two men and three women) in total hit the warning zone (zone 1) ﬁrst (see Table 4). Of these, warn
ings 3 and 4 (no outline and ﬁll and outline and ﬁll, respectively) recorded two hits each, whereas
warning 2 (outline and no ﬁll) was hit ﬁrst once. The frequency with which people hit each of the four
warning zones was also examined. This data are presented in Table 5.
Data were too limited to provide meaningful statistical analysis. Although the limited data preclude
the ability to provide conclusive results regarding the effect of outline and ﬁll to garner attention, we
can observe the following: there were no ﬁrst hits to warning 1, no outline/no ﬁll (see Figures 2 and, 3
and Table 4). Warnings similar in design to this (no outline and no ﬁll) are currently being used on
many of the OTC drugs in the market that are not child resistant.

CONCLUSIONS
Our study comprised of three objectives:
1. To test the relative prominence of a warning required by US law to be conspicuous when com
pared with other elements of the same label.
2. To explore how varying the graphic elements (an outline and background ﬁll) impacted its
noticeability when the placement and surface area of the warning were held constant.
3. To develop preliminary data to be used in a power analysis for future studies.
Objective 1. Consistent with other work, the warning was less noticeable than brand name for all
variables measured (time in zone, probability of ﬁrst hit and number of hits to zone) at a = 0.05. Com
parisons of the warning with the other zones (strength, net contents and product beneﬁts) were more
varied (see Figures 5–7).
Objective 2. With regard to inferences relating to objective 2, the ability of varied graphic elements to
garner consumer attention, our sample size (n = 17) severely limited our ability to make statistical
inferences. This was despite the fact that it was typical for an eye tracking study.17 Regardless, the fact
that the warnings designs were trending in the expected direction (see Tables 4 and 5) encourages
future study. Before future study can begin, a power analysis is needed.
Objective 3. Power analyses (see Figure 8) were performed. Between subject, variance (s2 = 38.69)
was considered equal; two expected mean differences (1.5 and 2.5 s) for the time spent in zone 1
(warning) were used in the power analysis. The analysis indicates that a sample size of over 980

Figure 8. Power versus sample size.

subjects would be required for expected mean difference of 1.5 s and that 190 subjects would be
required for 2.5 s to achieve 80% power.
That said, this study provides several interesting implications for future research. Eye tracking as a
method for the objective evaluation of attention has not been used very often in the ﬁeld of pack
aging,14,18–20 and of these studies, several track eye movement as subjects view a labels on a computer
screen, as opposed to allowing them to freely manipulate the package.18,19 Tracking on a computer
screen requires a ﬂattened image of the graphic information be presented, forcing exposure to all six
faces of the package. Our techniques allow subjects to freely manipulate the package by rotating it
to any face that they desire. As such, the study presented herein is among the ﬁrst to track subjects
on real packages, providing a more ecologically valid context for the collection of data regarding at
tentive behaviour.
This represents a methodology that has the potential to accurately characterize the attentive
behaviours of individuals, thereby objectively evaluating the effectiveness of varied elements of
package design.

LIMITATIONS
We purposefully limited our study’s scope such that it examined the ability of a warning, required by
law to be conspicuously displayed, to garner attention as measured with our Applied Science Labora
tories 501 eye tracking device. Although attention is requisite to comprehension and action, it is but a
single step in information processing. As such, we are limited in our ability to conjecture about the suc
cess or failure of the message in conveying information. Additionally, it should be noted that other fac
tors, not collected or reported herein, have the potential to signiﬁcantly inﬂuence the attentive
behaviours of subjects. For instance, Sansgiry and Cady21 found that elderly consumers ‘were more
involved in the decision making process to purchase OTC medications . . .. The elderly not only pur
chase and spend more money on medications but also read OTC labels completely.’ Key factors, such
as drug familiarity and consumer involvement with the drug, were not recorded and could have a
signiﬁcant effect in ﬁndings. Additionally, our subject population, composed of college students, is
not generalizable.
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